Scientists discover way to amp up power of killer T cells
Researchers with UCLA's Jonsson Comprehensive Cancer Center have discovered a way to amp up the power of killer T-cells, called CD8 cells, making them more functional for longer periods of time and boosting their ability ...
Medical research
May 10, 2011 |
4.8 / 5 (5) |
1
|
Revolutionary techniques could help harness patients' own immune cells to fight disease
The human body contains immune cells programmed to fight cancer and viral infections, but they often have short lifespans and are not numerous enough to overcome attacks by particularly aggressive malignancies ...
Medical research
Jan 03, 2013 |
5 / 5 (4) |
0
|
Cloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability ...
Cancer
Sep 13, 2012 |
4 / 5 (4) |
0
|
BRAF inhibitor treatment causes melanoma cells to shift how they produce energy
A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings, ...
Cancer
Mar 08, 2013 |
5 / 5 (3) |
0
|
Immortality gene mutation identifies brain tumors, other cancers
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research ...
Cancer
Mar 18, 2013 |
5 / 5 (3) |
0
|
Three new gene faults found to increase melanoma risk by 30 percent
An international team of researchers has discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour.
Genetics
Oct 09, 2011 |
4.7 / 5 (3) |
0
|
Tanning bed users exhibit brain changes and behavior similar to addicts
People who frequently use tanning beds may be spurred by an addictive neurological reward-and-reinforcement trigger, researchers at UT Southwestern Medical Center have found in a pilot study.
Psychology & Psychiatry
Aug 10, 2011 |
5 / 5 (2) |
0
|
Outwitting a brainy gene
(Medical Xpress) -- The very first in the series of mutations causing colon cancer occurs in the beta-catenin gene; this gene is abnormally activated in about 90 percent of colorectal cancer patients, and in a much smaller ...
Cancer
May 01, 2012 |
5 / 5 (2) |
0
People with darker skin still at risk for melanoma
(HealthDay) -- Skin cancer is more common among white people, but people with darker skin are also at risk, a dermatology expert cautions.
Cancer
Jul 26, 2012 |
5 / 5 (2) |
0
New study links tanning beds to non-melanoma skin cancer
Indoor tanning beds can cause non-melanoma skin cancer – and the risk is greater the earlier one starts tanning, according to a new analysis led by UCSF.
Cancer
Oct 02, 2012 |
5 / 5 (2) |
1
|
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR ...
Cancer
Nov 06, 2012 |
5 / 5 (2) |
0
Tapeworm DNA contains drug weak spots
For the first time, researchers have mapped the genomes of tapeworms to reveal potential drug targets on which existing drugs could act. The genomes provide a new resource that offers faster ways to develop urgently needed ...
Diseases, Conditions, Syndromes
Mar 13, 2013 |
5 / 5 (2) |
0
|
Using Viagra to combat malignant melanoma
Many tumors cause chronic inflammations, which, in their turn, suppress specific attacks against the tumor by the immune system. Scientists at the German Cancer Research Center and Medical Faculty Mannheim ...
Cancer
Nov 08, 2011 |
5 / 5 (1) |
0
|
Genetically engineering immune systems to fight melanoma: Clinical trial launched
Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer.
Cancer
Oct 01, 2012 |
5 / 5 (1) |
0
Researchers discover how melanoma cells circumvent the immune system
Melanoma is so dangerous because it tends to metastasize early on. New treatment approaches utilize, among other things, the ability of the immune defense to search out and destroy malignant cells. Yet this strategy is often ...
Cancer
Oct 10, 2012 |
5 / 5 (1) |
0
|
